Saxenda Clinical Trials
Here are the 6 most popular medical studies for saxenda
Glucagon-like peptide-1 (GLP-1) receptor agonist
Liraglutide for Hyperhidrosis
Recruiting1 awardPhase 2
Norfolk, Virginia
The purpose of this study is to conduct an interventional, one year, randomized, double blind, placebo-controlled trial with Liraglutide in patients with type 2 diabetes (diabetes duration of >6 months and <10 years, HbA1c <10%) to evaluate its effects on the peripheral autonomic nervous system, as well as inflammatory markers, and measures of oxidative and nitrosative stress.
Glucagon-like peptide-1 receptor agonist
LAPS-Exendin for Diabetes
Recruiting0 awardsPhase 1
California, California
A Phase 1b, Exploratory, Randomized, Partially Single Blinded, Placebo and Open Label Controlled, Parallel Group Study to Assess the Effects of HM11260C and an Active Comparator on Gastric Emptying and Beta-Cell Response in Subjects with Type 2 Diabetes Mellitus
Popular filter options for saxenda trials
Clinical Trials With No Placebo
View 21 medical studies that do not have a placebo group.
GLP-1 Receptor Agonist
Stem Cell Mobilization + Immunotherapy for Type 1 Diabetes
Recruiting1 awardPhase 1 & 2
Edmonton, Alberta
This trial is based on the "immunological reset" approach to treat type 1 diabetes. T-depletion therapy and anti-inflammatory treatment will restore self-tolerance in T1DM patients. Autologous, peripheral-blood mobilized hematopoietic CD34+-enriched stem cells and a long-acting GLP-1 analogue will promote pancreatic islet regeneration and repair.
Glucagon-like peptide agonist
Liraglutide for Type 1 Diabetes
Recruiting2 awardsPhase 3
Buffalo, New York
This trial will test the effect of liraglutide, a long-acting glucagon-like peptide-1 analog, on blood sugar control in adolescents with Type 1 diabetes. Liraglutide is already approved for the treatment of Type 2 diabetes in adults.
Glucagon-like peptide-1 receptor agonist
Semaglutide for Weight Management in Obesity
Recruiting3 awardsPhase 4
Loma Linda, California
This trial will see if semaglutide is better than existing anti-obesity meds in weight loss and quality of life, from a diverse group of participants from 3 US employers.
Glucagon-like peptide-1 receptor agonist
Liraglutide for Post-Sleeve Gastrectomy Obesity in Adolescents
Recruiting1 awardPhase 2
Bethesda, Maryland
This trial is testing whether liraglutide can help adolescents who still have obesity 1 year or more after vertical sleeve gastrectomy lose additional weight. Eligible participants must be between 12-20.99 years old, 1-10 years post vertical sleeve gastrectomy, and have a BMI of 30 kg/m2 or >=95th percentile for age and sex. The trial will last 7 months and involve 7 study visits.
View More Saxenda Trials
See another 6 medical studies focused on saxenda.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.